trending Market Intelligence /marketintelligence/en/news-insights/trending/i7t6gp0un9easezn1fagsg2 content esgSubNav
In This List

Aytu BioScience implements 1-for-20 reverse stock split

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Aytu BioScience implements 1-for-20 reverse stock split

Aytu BioScience Inc. implemented a 1-for-20 reverse split of its common stock, effective Aug. 10, to regain compliance with a Nasdaq Capital Market listing rule.

The Englewood, Colo.-based specialty healthcare company said its stock will begin trading on a split-adjusted basis on Aug. 13.

The reverse stock split, which was approved by the company's stockholders in June, will reduce the number of outstanding common stock to about 1.8 million shares from about 35.9 million shares.

In April, Aytu received a noncompliance notice from Nasdaq Stock Market for failing to meet the $1 minimum bid price listing requirement. The company has 180 days to achieve compliance.

V Stock Transfer LLC is acting as the exchange agent for the reverse stock split.